THE ASSOCIATION BETWEEN TREATMENT INTENSITY AND ADHERENCE TO LIPID-LOWERING THERAPIES AND CARDIOVASCULAR OUTCOMES IN PATIENTS WITH ATHEROSCLEROTIC CARDIOVASCULAR DISEASE IN PRIMARY AND SECONDARY CARE: A SWEDISH REGISTRY-BASED STUDY

被引：0
|
作者：
Leosdottir, M. [1 ]
Vilela, Sorio F. [2 ]
Svensson, Eriksson M. [3 ]
Villa, G. [2 ]
Banefelt, J. [4 ]
Lindh, M. [4 ]
Dun, Rieem A. [4 ]
Norhammar, A. [5 ]
机构：
[1] Skane Univ Hosp, Malmo, Sweden
[2] Amgen Europe GmbH, Rotkreuz, ZG, Switzerland
[3] Uppsala Univ, Uppsala, Sweden
[4] Quantify Res, Stockholm, AB, Sweden
[5] Karolinska Inst, Stockholm, Sweden
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
CL3
引用
收藏
页码：S407 / S407
页数：1
相关论文
共 50 条
  • [31] Impact of the 2013 Cholesterol Guideline on Patterns of Lipid-Lowering Treatment in Patients with Atherosclerotic Cardiovascular Disease or Diabetes After 1 Year
    Tran, Josephine N.
    Kao, Tzu Chun
    Caglar, Toros
    Stock, Karen M.
    Spertus, John A.
    Lew, Heidi C.
    Solow, Brian K.
    Chan, Paul S.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2016, 22 (08): : 901 - 908
  • [32] Clinical characteristics, patterns of lipid-lowering medication use, and health care resource utilization and costs among patients with atherosclerotic cardiovascular disease
    Power, Thomas P.
    Ke, Xuehua
    Zhao, Zhenxiang
    Bonine, Nicole Gidaya
    Cziraky, Mark J.
    Grabner, Michael
    Barron, John J.
    Quimbo, Ralph
    Vangerow, Burkhard
    Toth, Peter P.
    VASCULAR HEALTH AND RISK MANAGEMENT, 2018, 14 : 23 - 36
  • [33] Association between apical periodontitis and secondary outcomes of atherosclerotic cardiovascular disease: A case-control study
    Malvicini, Giulia
    Marruganti, Crystal
    Abu Leil, Mustafa
    Martignoni, Marco
    Pasqui, Edoardo
    de Donato, Gianmarco
    Grandini, Simone
    Gaeta, Carlo
    INTERNATIONAL ENDODONTIC JOURNAL, 2024, 57 (03) : 281 - 296
  • [34] Longitudinal evaluation of treatment patterns, risk factors and outcomes in patients with cardiovascular disease treated with lipid-lowering therapy in the UK
    Danese, Mark
    Sidelnikov, Eduard
    Villa, Guillermo
    Catterick, David
    Iqbal, Mazhar
    Gleeson, Michelle
    Lubeck, Deborah
    Patel, Jeetesh
    BMJ OPEN, 2022, 12 (04):
  • [35] Effect of Lipid-Lowering Drugs on Renal and Cardiovascular Outcomes in Patients with Chronic Kidney Disease and Dyslipidemia: A Retrospective Cohort Study
    Lin, Yi-Chih
    Tsao, Hsiao-Mei
    Lai, Tai-Shuan
    Chen, Yi-Ting
    Chou, Yu-Hsiang
    Lin, Shuei-Liong
    Chen, Yung-Ming
    Hung, Kuan-Yu
    Tu, Yu-Kang
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 114 (06) : 1366 - 1374
  • [36] Adherence to lipid-lowering therapy and risk for cardiovascular disease and death in type 1 diabetes mellitus: a population-based study from the Swedish National Diabetes Register
    Hero, Christel
    Karlsson, Sofia Axia
    Franzen, Stefan
    Svensson, Ann-Marie
    Miftaraj, Mervete
    Gudbjornsdottir, Soffia
    Andersson Sundell, Karolina
    Eliasson, Bjorn
    Eeg-Olofsson, Katarina
    BMJ OPEN DIABETES RESEARCH & CARE, 2020, 8 (01)
  • [37] Long-term achievement of the therapeutic objectives of lipid-lowering agents in primary prevention patients and cardiovascular outcomes: An observational study
    Van Ganse, E
    Souchet, T
    Laforest, L
    Moulin, P
    Bertrand, M
    Le Jeunne, P
    Chretin, S
    Yin, D
    Alemao, E
    de Pouvourville, G
    ATHEROSCLEROSIS, 2006, 185 (01) : 58 - 64
  • [38] Treatment patterns of lipid-lowering therapies and possible statin intolerance among statin users with clinical atherosclerotic cardiovascular disease (ASCVD) or diabetes mellitus (DM) in Taiwan
    Chen, Wen-Jone
    Wen, Yao-Chun
    Fox, Kathleen M.
    Shen, Li-Jiuan
    Lin, Lian-Yu
    Qian, Yi
    Zhao, Zhongyun
    Rane, Pratik P.
    Hsiao, Fei-Yuan
    JOURNAL OF EVALUATION IN CLINICAL PRACTICE, 2020, 26 (04) : 1171 - 1180
  • [39] Low-density lipoprotein cholesterol outcomes post-non-PCSK9i lipid-lowering therapies in atherosclerotic cardiovascular disease and probable heterozygous familial hypercholesterolemia patients
    Chen, Chi-Chang
    Rane, Pallavi B.
    Hines, Dionne M.
    Patel, Jeetvan
    Harrison, David J.
    Wade, Rolin L.
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2018, 14 : 2425 - 2435
  • [40] LIPID-LOWERING TREATMENT PATTERNS AND POSSIBLE ASSOCIATED STATIN INTOLERANCE IN PATIENTS WITH CLINICAL ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (ASCVD) OR DIABETES MELLITUS (DM) IN TAIWAN
    Chen, W.
    Wen, Y.
    Hsiao, F.
    Fox, K. M.
    Lin, L.
    Shen, L.
    Qian, Y.
    Zhao, Z.
    Rane, P. P.
    VALUE IN HEALTH, 2017, 20 (09) : A631 - A631
12345